E-LIB Suche - Ergebnisse für: Aglitti, Andrea

1

Olmesartan-induced enteropathy: More than one entity?:

Famularo, Giuseppe ; Aglitti, Andrea ; Magrini, Laura
European Journal of Internal Medicine. 105 (2022) - p. 113 , 2022

2

Corrigendum to "Role of Oxidative Stress in Pathophysiology..:

Masarone, Mario ; Rosato, Valerio ; Dallio, Marcello...
Oxidative Medicine and Cellular Longevity. 2021 (2021) - p. 1-1 , 2021

Link: https://doi.org/10.1155/..

3

Characterisation of asymptomatic patients and efficacy of p..:

Masarone, Mario ; Vaccaro, Emilia ; Sciorio, Roberta...
BMJ Open. 11 (2021) 5 - p. e043112 , 2021

Link: https://doi.org/10.1136/..

4

Untargeted metabolomics as a diagnostic tool in NAFLD: disc..:

Masarone, Mario ; Troisi, Jacopo ; Aglitti, Andrea...
Metabolomics. 17 (2021) 2 - p. , 2021

Link: https://doi.org/10.1007/..

5

Incidence of HCC recurrence after DAA treatment for HCV in ..:

Guarino, Maria ; Di Costanzo, Giovan Giuseppe ; Bruzzese, Dario...
Liver Cancer International. 1 (2020) 1 - p. 12-24 , 2020

Link: https://doi.org/10.1002/..

6

Hepatitis C virus infection in jail: Difficult-to-reach, no..:

Masarone, Mario ; Caruso, Rosa ; Aglitti, Andrea...
Digestive and Liver Disease. 52 (2020) 5 - p. 541-546 , 2020

Link: https://doi.org/10.1016/..

7

Efficacy and safety of glecaprevir/pibrentasvir in renally ..:

Lawitz, Eric ; Flisiak, Robert ; Abunimeh, Manal...
Liver International. 40 (2019) 5 - p. 1032-1041 , 2019

Link: https://doi.org/10.1111/..

8

HCV point‐of‐care screening programme and treatment options..:

Persico, Marcello ; Masarone, Mario ; Aglitti, Andrea...
Liver International. 39 (2019) 10 - p. 1845-1851 , 2019

Link: https://doi.org/10.1111/..

9

Predictors of hepatocellular carcinoma in HCV cirrhotic pat..:

Lleo, Ana ; Aglitti, Andrea ; Aghemo, Alessio...
Digestive and Liver Disease. 51 (2019) 2 - p. 310-317 , 2019

Link: https://doi.org/10.1016/..

10

Real‐life efficacy and safety of glecaprevir/pibrentasvir i..:

Persico, Marcello ; Aglitti, Andrea ; Caruso, Rosa...
GastroHep. , 2019

Link: https://doi.org/10.1002/..

11

Real‐life glecaprevir/pibrentasvir in a large cohort of pat..:

Persico, Marcello ; Aglitti, Andrea ; Milella, Michele...
Liver International. 39 (2019) 10 - p. 1852-1859 , 2019

Link: https://doi.org/10.1111/..

12

THU-168-Real-life effectivness and safety of glecaprevir/pi..:

Persico, Marcello ; Aglitti, Andrea ; Caruso, Rosa...
Journal of Hepatology. 70 (2019) 1 - p. e236 , 2019

Link: https://doi.org/10.1016/..

13

NAFLD and Extra-Hepatic Comorbidities: Current Evidence on ..:

Rosato, Valerio ; Masarone, Mario ; Dallio, Marcello...
International Journal of Environmental Research and Public Health. 16 (2019) 18 - p. 3415 , 2019

Link: https://doi.org/10.3390/..

14

FRI-326-Preclinical evaluation of endothelial dysfunction b..:

Masarone, Mario ; Troisi, Jacopo ; Calvanese, Gemma...
Journal of Hepatology. 70 (2019) 1 - p. e539 , 2019

Link: https://doi.org/10.1016/..

15

Overview of Immune Checkpoint Inhibitors Therapy for Hepato..:

Giannini, Edoardo ; Aglitti, Andrea ; Borzio, Mauro...
Cancers. 11 (2019) 11 - p. 1689 , 2019

Link: https://doi.org/10.3390/..